Tamsulosin: an overview

Research output: Contribution to journalArticle

Abstract

This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Urology and Nephrology

Keywords

  • benign prostatic hyperplasia, pharmacotherapy, alpha antagonists
Original languageEnglish
Pages (from-to)397-404
JournalWorld Journal of Urology
Volume19
Issue number6
Publication statusPublished - 2002
Publication categoryResearch
Peer-reviewedYes